We are live on ! Find out more
CALA

Calithera Biosciences, Inc
CALA

Delisted

CALA was delisted on the 1st of February, 2023.

Back to rankings

105 hedge funds and large institutions have $262M invested in Calithera Biosciences, Inc in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 28 increasing their positions, 35 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 17

45% more capital invested

Capital invested by funds: $181M → $262M (+$81.1M)

8% more funds holding

Funds holding: 97 → 105 (+8)

1% less call options, than puts

Call options by funds: $11.6M | Put options by funds: $11.7M

20% less repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 35

Holders
105
Holders Change
+8
Holders Change %
+8.25%
% of All Funds
1.86%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
28
Reduced
35
Closed
17
Calls
$11.6M
Puts
$11.7M
Net Calls
-$127K
Net Calls Change
-$283K

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$8.76M
2
BlackRock
BlackRock
New York
+$2.37M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$1.34M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.16M
5
TCMG
TSP Capital Management Group
New Jersey
+$896K

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$8.88M
2
GPP
Great Point Partners
Connecticut
-$4.7M
3
Renaissance Technologies
Renaissance Technologies
New York
-$3.67M
4
MWNA
Marshall Wace North America
New York
-$1.86M
5
Norges Bank
Norges Bank
Norway
-$1.31M
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
101
Royal Bank of Canada
Ontario, Canada
$5K +$4.29K +49 New
TC
102
Truvestments Capital
Florida
$4K +$3.59K +41 New
Osaic Holdings
103
Osaic Holdings
Arizona
$2K – – –
Daiwa Securities Group
104
Daiwa Securities Group
Japan
$1K +$614 +7 New
AIG
105
American International Group
New York
$188 -$4.73K -54 -3%
Assenagon Asset Management
106
Assenagon Asset Management
Luxembourg
– -$690K -9,995 Closed
Millennium Management
107
Millennium Management
New York
– -$603 -8,745 Closed
Man Group
108
Man Group
United Kingdom
– -$421K -6,106 Closed
CCM
109
CAAS Capital Management
New York
– -$333K -3,794 Closed
AC
110
Athanor Capital
New York
– -$169K -2,443 Closed
PP
111
PDT Partners
New York
– -$82K -1,191 Closed
HW
112
Hancock Whitney
Mississippi
– -$79K -1,141 Closed
WS
113
Wedbush Securities
California
– -$71K -1,025 Closed
BFM
114
Boothbay Fund Management
New York
– -$68K -980 Closed
JF
115
Jump Financial
Illinois
– -$65K -940 Closed
VF
116
Virtu Financial
New York
– -$62K -896 Closed
Jane Street
117
Jane Street
New York
– -$66K -753 Closed
Fidelity Investments
118
Fidelity Investments
Massachusetts
– -$20K -285 Closed
PHK
119
Point72 Hong Kong
Hong Kong
– -$3K -44 Closed
PFS
120
Prospera Financial Services
Texas
– -$2K -25 Closed
ASN
121
Advisory Services Network
Georgia
– -$1K -15 Closed
1 2 3 4
5

CALA Hedge Fund Activity: Q4 2020 in Review

105 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q4 2020, worth a combined $262M — up 45% from $181M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new CALA positions and 17 closed out — a net gain of 9 holders — while 28 added to existing stakes and 35 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $8.76M. The largest seller was Point72 Asset Management, cutting an estimated $8.88M.

  • 105 institutional investors held Calithera Biosciences, Inc (CALA) as of Q4 2020, up from 97 in Q3 2020.
  • Funds reported $262M of Calithera Biosciences, Inc stock for Q4 2020, up 45% quarter-over-quarter.
  • 26 funds opened new Calithera Biosciences, Inc positions in Q4 2020 and 17 closed out, a net change of +9 holders.
  • The largest Calithera Biosciences, Inc buyer in Q4 2020 was Adage Capital Partners, an estimated $8.76M added.
  • The largest Calithera Biosciences, Inc seller in Q4 2020 was Point72 Asset Management, an estimated $8.88M sold.

Based on aggregated 13F filings for Q4 2020.